SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-025198
Filing Date
2024-06-26
Accepted
2024-06-26 07:00:40
Documents
15
Period of Report
2024-06-24
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 49417
2 ex16.htm EX-16 3731
  Complete submission text file 0001493152-24-025198.txt   277494

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE hrow-20240624.xsd EX-101.SCH 3944
4 XBRL DEFINITION FILE hrow-20240624_def.xml EX-101.DEF 26962
5 XBRL LABEL FILE hrow-20240624_lab.xml EX-101.LAB 37183
6 XBRL PRESENTATION FILE hrow-20240624_pre.xml EX-101.PRE 25582
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6652
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 241070597
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)